Cargando…
A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres
SIMPLE SUMMARY: Doxorubicin (DOX) is widely used in the treatment of breast cancer. However, resistance limits its effectiveness. In particular, breast cancer stem cells (BCSCs) are associated with DOX resistance. We have previously demonstrated the potential of a polymeric nanocarrier based on a su...
Autores principales: | Stagni, Venturina, Kaminari, Archontia, Contadini, Claudia, Barilà, Daniela, Sessa, Rosario Luigi, Sideratou, Zili, Vlahopoulos, Spiros A., Tsiourvas, Dimitris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000448/ https://www.ncbi.nlm.nih.gov/pubmed/36900267 http://dx.doi.org/10.3390/cancers15051474 |
Ejemplares similares
-
A Triphenylphosphonium-Functionalized Mitochondriotropic Nanocarrier for Efficient Co-Delivery of Doxorubicin and Chloroquine and Enhanced Antineoplastic Activity
por: Panagiotaki, Katerina N., et al.
Publicado: (2017) -
Carbon Dots–Biomembrane Interactions and Their Implications for Cellular Drug Delivery
por: Mavroidi, Barbara, et al.
Publicado: (2023) -
Engineering Mitochondriotropic Carbon Dots for Targeting Cancer Cells
por: Kaminari, Archontia, et al.
Publicado: (2021) -
ITCH E3 ligase in ATM network
por: Stagni, Venturina, et al.
Publicado: (2014) -
Multi-Walled Carbon Nanotubes Decorated with Guanidinylated Dendritic Molecular Transporters: An Efficient Platform for the Selective Anticancer Activity of Doxorubicin
por: Lyra, Kyriaki-Marina, et al.
Publicado: (2021)